Correlation Between Dupont De and Kinnate Biopharma
Can any of the company-specific risk be diversified away by investing in both Dupont De and Kinnate Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Kinnate Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Kinnate Biopharma, you can compare the effects of market volatilities on Dupont De and Kinnate Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Kinnate Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Kinnate Biopharma.
Diversification Opportunities for Dupont De and Kinnate Biopharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dupont and Kinnate is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Kinnate Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kinnate Biopharma and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Kinnate Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kinnate Biopharma has no effect on the direction of Dupont De i.e., Dupont De and Kinnate Biopharma go up and down completely randomly.
Pair Corralation between Dupont De and Kinnate Biopharma
If you would invest 8,327 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 63.00 from holding Dupont De Nemours or generate 0.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Dupont De Nemours vs. Kinnate Biopharma
Performance |
| Timeline |
| Dupont De Nemours |
| Kinnate Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Dupont De and Kinnate Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dupont De and Kinnate Biopharma
The main advantage of trading using opposite Dupont De and Kinnate Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Kinnate Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kinnate Biopharma will offset losses from the drop in Kinnate Biopharma's long position.| Dupont De vs. Eastman Chemical | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc | Dupont De vs. Sherwin Williams Co |
| Kinnate Biopharma vs. ACELYRIN, INC Common | Kinnate Biopharma vs. Windtree Therapeutics | Kinnate Biopharma vs. Palisade Bio | Kinnate Biopharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |